Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications

Front Endocrinol (Lausanne). 2024 Apr 12:15:1343255. doi: 10.3389/fendo.2024.1343255. eCollection 2024.

Abstract

Stem cell-based therapies exhibit considerable promise in the treatment of diabetes and its complications. Extensive research has been dedicated to elucidate the characteristics and potential applications of adipose-derived stromal/stem cells (ASCs). Three-dimensional (3D) culture, characterized by rapid advancements, holds promise for efficacious treatment of diabetes and its complications. Notably, 3D cultured ASCs manifest enhanced cellular properties and functions compared to traditional monolayer-culture. In this review, the factors influencing the biological functions of ASCs during culture are summarized. Additionally, the effects of 3D cultured techniques on cellular properties compared to two-dimensional culture is described. Furthermore, the therapeutic potential of 3D cultured ASCs in diabetes and its complications are discussed to provide insights for future research.

Keywords: adipose-derived stem/stromal cells; diabetes mellitus; diabetic foot ulcer; monolayer culture; three-dimensional culture.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue* / cytology
  • Animals
  • Cell Culture Techniques / methods
  • Cell Culture Techniques, Three Dimensional / methods
  • Cell Differentiation
  • Diabetes Complications / therapy
  • Diabetes Mellitus* / therapy
  • Humans
  • Mesenchymal Stem Cells / cytology

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by the National Natural Science Foundation of China (82170822, 82070809, 82300895, and 81900734).